Sight Sciences Profit Margin

The latest profit margin for SGHT is -35.69% as of June 2026. That compares with -64.23% in the prior-year period — up 44.4% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Sight Sciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, SGHT's profit margin moved from -64.23% to -35.69% — a 44.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sight Sciences's valuation or profitability profile.

Against Healthcare companies, SGHT currently prints -35.69% for profit margin, while the sector average sits near 14.34%. That is roughly 348.8% below the sector mean. Large gaps often invite a closer look at Sight Sciences's growth, margins, and balance sheet.

Profit Margin shows how effectively Sight Sciences converts resources into returns. At -35.69%, SGHT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -64.23% in the prior-year period — up 44.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SGHT's profit margin (-35.69%), review year-over-year change from -64.23%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.